Anti-APP Abeta40重组抗体|科研级 Ponezumab ( 泊奈组单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-APP Abeta40重组抗体|科研级 Ponezumab ( 泊奈组单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-APP Abeta40重组抗体|科研级 Ponezumab ( 泊奈组单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1248

Alias

科研级 Ponezumab ( 泊奈组单抗 ), Anti-APP Abeta40 Recombinant Antibody, Research Grade Ponezumab

Molecular Name

Ponezumab

Size

1mg, 5mg

CAS Number

1178862-65-1

Isotype

IgG2 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Applications

ELISA, IP, FC, FuncS, Neut

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

APP Abeta40[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease. Ponezumab was developed by Pfizer Inc. In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ